Vertical has acquired U.S. rights to the sci-fi horror thriller The Cure, slating it for release in select theaters and on demand in 2026, Deadline reports.
Samantha Cochran (V/H/S/Halloween) stars alongside David Dastmalchian (Late Night with the Devil) and Ashley Greene (Twilight).
The film follows Ally Braun (Cochran), an adopted 16-year-old suffering from a mysterious illness, who discovers her biotech billionaire parents (Dastmalchian & Greene) are harvesting her blood for sinister purposes.
Nancy Leopardi directs from a script by Jonathan Bernstein & James Greer (Unsane).
Sydney Taylor (“American Born Chinese”), Tyler Lawrence Gray (“Wolfpack”), and Dylan Flashner (The Card Counter) round out the cast.
Leopardi, who describes the film “a satirical take on the modern billionaire class cloaked in a crowd-pleasing thriller,” produces alongside Bo Youngblood, John Ierardi, and Natalie Marciano
“The Cure is made in the tradition of classic horror and sci-fi films that are inspired by terrifying socio-political realities and advances in bio-technology,” said Leopardi. “Like Ex Machina, A.I., and Videodrome, I believe we are on the cusp of a revolution in science and the big question is – who will benefit?”
Vaneast Pictures is representing the project for international sales at the American Film Market.
Ashley Greene in ‘It Feeds’
The post ‘The Cure’ Starring David Dastmalchian & Ashley Greene Acquired by Vertical for 2026 Release appeared first on Bloody Disgusting!.
